From Casetext: Smarter Legal Research

KING PHARMACEUTICALS, INC v. EON LABS, INC.

United States Court of Appeals, Federal Circuit
Mar 25, 2011
No. 2011-1070 (Fed. Cir. Mar. 25, 2011)

Opinion

No. 2011-1070.

March 25, 2011.

Appeal from the United States District Court for the Eastern District of New York in case no. 04-CV-5540, Senior Judge David G. Trager.


ON MOTION ORDER

Eon Labs, Inc. moves for a 14-day extension of time, until April 7, 2011, to respond to Elan Pharmaceuticals, Inc.'s Motion for Fees and Costs and for a 14-day extension of time, until April 8, 2011, to file its reply brief.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motions for extensions of time are granted.

(2) The motion for fees and costs is deferred for consideration by the merits panel. Copies of this order, the motion, and any response or reply shall be transmitted to the merits panel.


Summaries of

KING PHARMACEUTICALS, INC v. EON LABS, INC.

United States Court of Appeals, Federal Circuit
Mar 25, 2011
No. 2011-1070 (Fed. Cir. Mar. 25, 2011)
Case details for

KING PHARMACEUTICALS, INC v. EON LABS, INC.

Case Details

Full title:KING PHARMACEUTICALS, INC. AND KING PHARMACEUTICALS RESEARCH AND…

Court:United States Court of Appeals, Federal Circuit

Date published: Mar 25, 2011

Citations

No. 2011-1070 (Fed. Cir. Mar. 25, 2011)